[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 42,324
Sort by:

Italian Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

This report presents a comprehensive analysis of the Italian molecular diagnostics market, including: Major issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

March 2013 850 pages

Spanish Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including: Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

March 2013 850 pages

UK Molecular Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

This report presents a comprehensive analysis of the UK molecular diagnostics market, including: Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...

March 2013 855 pages

Lung Cancer Diagnostics Market Analysis By Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), By Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), And Segment Forecasts To 2024

US$ 5,950.00

... The development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast ... period. These diagnostic tools facilitate the personalized treatment approach ...

March 2013 94 pages

Cardiac Rhythm Management (CRM) Market Report: 2012 Edition

US$ 800.00

Cardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used for the treatment of arrhythmias and ...

February 2013 45 pages

Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK

US$ 15,760.00

... Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in ... basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly ...

February 2013 820 pages

Competing in the European Hematology and Flow Cytometry Markets: France, Germany, Italy, Spain, UK

US$ 15,760.00

... and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next five years. The ... forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and ...

February 2013 450 pages

Competing in the European Infectious Disease Testing Market: France, Germany, Italy, Spain, UK

US$ 15,760.00

... opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in major European countries (France, Germany, Italy, Spain, UK); assessment of emerging technologies; review of current instrumentation; as well as strategic profiles ...

February 2013 1600 pages

Competing in the French Diagnostic Testing Marekt: Forecasts by Market Segment and Supplier Shares by Test

US$ 3,120.00

This new report from Venture Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood ...

February 2013 58 pages

Competing in the German Diagnostic Testing Market: Forecasts by Market Segment and Supplier Shares by Test

US$ 3,120.00

This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood ...

February 2013 61 pages

Competing in the Italian Diagnostic Testing Market: Forecasts by Market Segment and Supplier Shares by Test

US$ 3,120.00

This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

February 2013 57 pages

Competing in the Japanese Diagnostic Testing Market: Forecasts by Market Segment and Supplier Shares by Test

US$ 3,120.00

This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

February 2013 60 pages

Competing in the Spanish Diagnostic Testing Market: Forecasts by Market Segment and Supplier Shares by Test

US$ 3,120.00

This new report from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

February 2013 56 pages

Competing in the UK Diagnostic Testing Market: Forecasts by Marke Segment and Supplier Shares by Test

US$ 3,120.00

This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

February 2013 64 pages

Competing in the US Diagnostic Testing Market: Forecasts by Market Segment and Supplier Shares by Test

US$ 3,480.00

This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

February 2013 101 pages

Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends)

US$ 3,995.00

This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the ... Laboratory Information Management Systems (LIMS) As a report with international focus, markets for North America, Europe and Asia are provided. Revenues ...

February 2013 200 pages

Competing in the US Cancer Diagnostics Market

US$ 7,840.00

... trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Five- ...

February 2013 620 pages

Competing in the US Clinical Chemistry and Immunodiagnostic Markets

US$ 9,200.00

... . Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

February 2013 600 pages

Competing in the US Coagulation Market

US$ 7,680.00

... and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads. Placement estimates for major ...

February 2013 424 pages

Competing in the US Hematology and Flow Cytometry Markets

US$ 7,880.00

This new 275-page report from Venture Planning Group contains 42 tables, and presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and ...

February 2013 275 pages

Competing in the US Infectious Disease Testing Market

US$ 7,880.00

This new 1,037-page report from Venture Planning Group contains 177 tables, and presents a comprehensive analysis of the US infectious disease testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...

February 2013 1037 pages

Competing in the US Molecular Diagnostics Market

US$ 7,600.00

... . Feature comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, ...

February 2013 880 pages

US Hematology and Flow Cytometry Market Outlook: Innovations, Trends and Opportunities for Suppliers

US$ 7,880.00

... - and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in US hospitals, commercial laboratories, physician offices and ambulatory care centers. Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and ...

February 2013 275 pages

2013 Analysis of the Global Blood Banking Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers

US$ 6,000.00

This new 340-page report from Venture Planning Group provides analysis of the global blood banking market, including emerging tests, technologies, ... and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S. Comprehensive analysis of the clinical significance and market needs for major blood ...

February 2013 340 pages

Future US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018

US$ 3,880.00

... to be made in the future, and enhances corporate ability to develop realistic contingency plans. The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact as well as five - and ten- ...

February 2013 135 pages

Emerging Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 10,000.00

... Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume ... coagulation procedures by market segment: Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine ...

February 2013 1007 pages

Micro and Nano Technologies for Point-of-Care Testing

US$ 3,040.00

... pharmacogenomics); and cancer screening/pharmacogenomics - are forecast to grow at CAGRs of 14%, 22%, 19% and 30% respectively. Your key questions answered Which micro and nano technologies in development offer the attributes of miniat What drivers and restraints operate in the nascent market for POC ...

February 2013

2013 Analysis of the Global Coagulation Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers

US$ 6,000.00

This new 302-page report from Venture Planning Group provides analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of coagulation testing ...

February 2013 302 pages

2013 Analysis of the Global Hematology and Flow Cytometry Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

US$ 6,000.00

This new 178-page report from Venture Planning Group provides analysis of the global hematology and flow cytometry market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated number of hematology ...

February 2013 178 pages

In-Vitro Diagnostics Market Analysis to 2017

US$ 1,500.00

... Brazil. In their latest research study, “In-Vitro Diagnostics Market Analysis to 2017”, RNCOS analysts identified market dynamics in various important regions to highlight ... that together constitute around 95% of the global market, have been profiled. Further, the market has been divided into eight distinct ...

February 2013 140 pages

Therapeutic Class Report Overview : Hepatitis C Virus Infection

US$ 1,000.00

... betting on vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the ...

February 2013 31 pages

India Genetic Testing Market Analysis

US$ 600.00

... . Genetic testing market in India was initially limited to very few organizations in the country, which possessed both the expertise and the capability to conduct screening tests ... . The success of genetic testing in India depends on overcoming major challenges that span around this field. Since India is one of the emerging markets and being looked ...

February 2013 90 pages

European Markets for Diabetes Monitoring, Treatment and Drug Delivery

US$ 10,995.00

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019. This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, ...

January 2013 250 pages

U.S. Market for Interventional Cardiology Devices

US$ 6,995.00

... for a great deal of the growth in the total market for interventional cardiology devices in the United States. Many of the established standard items ... St.Jude Medical Medtronic Cordis Cook Medical Vascular Solutions MedRAD Interventional/Possis Terumo Covidien Galt Medical This report analyzes and ...

January 2013 334 pages

Competitive Intelligence: Leading Tumor Marker Diagnostics Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 2,000.00

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...

January 2013 80 pages

Competitive Intelligence: Leading Transfusion Diagnostic Testing Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,480.00

This new report from Venture Planning Group provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements ...

January 2013 50 pages

ELI LILLY - Relief from Tax rate but unsustainable beyond 2013 due to high impact Cymbalta loss

US$ 90.00

... is mainly due to the potential R&D tax credit which will be realized from 1Q 2013. But beyond 2013, we see loss of Cymbalta sales to generic ... price. Despite the increasing growth of diabetes therapy, the revenues from Humulin and Humalog continued to be flat due to competition.

January 2013 1 pages

Competitive Intelligence: World Blood Banking Market Key Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,480.00

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios ...

January 2013 50 pages

Competitive Intelligence: World Clinical Chemistry and Immunodiagnostics Market Key Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

US$ 1,480.00

... chemistry and immunodiagnostic product suppliers and emerging market entrants.The report presents strategic profiles of 25 current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, ...

January 2013 42 pages

Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

US$ 2,401.00

... your work. Visiongain has determined that the value of the global companion diagnostics market will reach $19.3bn in 2023. What makes this ... highlighting key business opportunities. Why you should buy Top Companion Diagnostic Companies: Competitive Analysis 2013-2023 137 pages of comprehensive analysis ...

January 2013 157 pages

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

US$ 4,500.00

... been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal ... , Tissue Microarrays and Mass Spectroscopy Integrated Sample-to-Results Testing Market size and forecasts in the report are for manufacturer's revenues ...

January 2013 880 pages

2013 French Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... -page report from Venture Planning Group presents a comprehensive analysis of the French microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 980 pages

2013 German Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... -page report from Venture Planning Group presents a comprehensive analysis of the German microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 983 pages

2013 Italian Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... new 970-page report from Venture Planning Group comprehensive analysis of the Italian microbiology testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views ...

January 2013 970 pages

2013 Japanese Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 6,240.00

... -page report from Venture Planning Group presents a comprehensive analysis of the Japanese microbiology testing market, including: Major issues pertaining to the ... , and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed ...

January 2013 976 pages

2013 Spanish Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 960 pages

2013 UK Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 4,720.00

... 978-page report from Venture Planning Group presents a comprehensive analysis of the UK microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 978 pages

2013 US Microbiology Testing Market: Opportunities and Strategies for Suppliers

US$ 7,520.00

... 1,037-page report from Venture Planning Group presents a comprehensive analysis of the US microbiology testing market, including: Major issues pertaining to the ... on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly ...

January 2013 1037 pages

US Telelaparoscopy Opportunity Analysis

US$ 1,000.00

... Our extensive research and analysis have led us to identify three areas, where unlimited opportunities lie. Amongst these, “US Telelaparoscopy Opportunity Analysis”, provides insights on the Telelaparoscopy general surgery. Presented in 25 slides, this report unfolds the tremendous scope of Telelaparoscopy - ...

December 2012 25 pages

Disease Management and Health Monitoring for ACOs 1Q 2013

US$ 3,500.00

... ) and Accountable Care Organization (ACO). It analyzes how care management services and home health monitoring technologies will be deployed in these new care services ... ACO structure and operational models will influence adoption of care management service and health monitoring technologies.”

December 2012 68 pages

Filters

Search

Categories

675
84
1,065
32,618
152
69
819
657
1,864
4,251
70

Publishers

8
9
35
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
47
11
77
1
14
2
22
3
74
40,224
1
40
2
17
15
24
85
6
10
50
11
62
48
1
45
23
49

Regions

281
15
1
135
138
138
138
137
136
136
135
132
131
179
38
15,330
450
193
192
192
138
4
3
2
199
198
197
197
197
196
195
195
195
193
106
194
196
195
193
107
197
139
204
195
190
201
199
197
139
105
196
195
195
195
196
177
200
198
139
112
198
198
196
196
194
194
139
139
136
136
136
1
1
201
199
198
196
195
199
197
197
196
196
196
195
195
195
196
196
193
139
139
138
108
16
1
1
199
1
108
1,216
1,214
1,198
1,193
1,173
246
2
264
195
196
204
198
1,228
1,153
1,669

Price

Date

Pages

Offers

33
6
1
15
84